Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
Date | Form | Description | Docs | XBRL | Pages |
07/14/20 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
![]() ![]() |
57 | |
07/14/20 | 8-K | Current report filing |
![]() ![]() |
44 | |
07/13/20 | 8-K | Current report filing |
![]() ![]() |
5 | |
07/10/20 | 8-K | Current report filing |
![]() ![]() |
5 | |
07/07/20 | 8-K | Current report filing |
![]() ![]() |
41 | |
06/29/20 | 8-K | Current report filing |
![]() ![]() |
5 | |
06/29/20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
![]() ![]() |
5 | |
06/22/20 | 8-K | Current report filing |
![]() ![]() |
7 | |
06/19/20 | 8-K | Current report filing |
![]() ![]() |
3 | |
06/18/20 | 8-K | Current report filing |
![]() ![]() |
6 |